These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29349757)

  • 1. Management of the Axilla in Early Breast Cancer.
    Valero MG; Golshan M
    Cancer Treat Res; 2018; 173():39-52. PubMed ID: 29349757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
    Garcia-Etienne CA; Ferrari A; Della Valle A; Lucioni M; Ferraris E; Di Giulio G; Squillace L; Bonzano E; Lasagna A; Rizzo G; Tancredi R; Scotti Foglieni A; Dionigi F; Grasso M; Arbustini E; Cavenaghi G; Pedrazzoli P; Filippi AR; Dionigi P; Sgarella A
    Eur J Surg Oncol; 2020 Jan; 46(1):15-23. PubMed ID: 31445768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation of axillary surgery in early breast cancer.
    Jatoi I; Benson JR; Toi M
    Lancet Oncol; 2016 Oct; 17(10):e430-e441. PubMed ID: 27733269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Management of the Axilla.
    McCARTAN D; Gemignani ML
    Clin Obstet Gynecol; 2016 Dec; 59(4):743-755. PubMed ID: 27660930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.
    Bassi KK; Seenu V; Srivastava A; Al Sharara N
    Indian J Cancer; 2012; 49(1):66-73. PubMed ID: 22842171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
    Cserni G
    Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes?
    Dominici L; Golshan M
    Minerva Chir; 2010 Oct; 65(5):547-54. PubMed ID: 21081866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
    Lee MC; Joh JE; Chau A
    Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
    Agarwal A; Heron DE; Sumkin J; Falk J
    J Surg Oncol; 2005 Oct; 92(1):4-8. PubMed ID: 16180213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Azghadi S; Daly M; Mayadev J
    Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.